Showing 1 - 10 of 1,310
This paper studies the effect of two regulatory instruments - a price cap and a reference price system - a mandatory substitution rule, and the combination of both on generic competition in a Salop-type model with an off-patent brand-name drug and n differentiated generic versions. The price cap...
Persistent link: https://www.econbiz.de/10010510801
Before it can sell a prescription drug lawfully in interstate commerce, a manufacturer must prove to the satisfaction of the Food and Drug Administration that the drug is both safe and effective. Congress approved this requirement in 1962 unanimously. Four decades of changes in the drug market...
Persistent link: https://www.econbiz.de/10014058315
This paper studies the effect of pharmaceutical regulation at the wholesale level, if markets are integrated by parallel trade, i.e. trade outside the manufacturers authorized distribution channel. In particular, maximum wholesale margins, a restriction of pricing by the intermediary, and...
Persistent link: https://www.econbiz.de/10013061754
This paper uses macro-level data between 1997 and 2008 to evaluate the effects of China's pharmaceutical price regulations. We find that these regulations had short-run effects on medicine price indices, reducing them by less than 0.5 percentage points. The effects could have been slightly...
Persistent link: https://www.econbiz.de/10013066440
This paper studies interaction of pharmaceutical regulation and parallel trade in a North-South framework. An innovative Örm located in the North can sell its drug only in the North or in both countries. Governments may limit reimbursement for the drug. Reimbursement limits reduce the Örmís...
Persistent link: https://www.econbiz.de/10011290061
I study the passthrough of regulated ad valorem pharmacy markups and reduced Value Added Tax (VAT) rates to pharmaceutical retail prices in Finland. My reduced form evidence shows that pharmaceutical manufacturers respond to a decrease in regulated pharmacy markups by increasing their wholesale...
Persistent link: https://www.econbiz.de/10015173440
international burden-sharing system. In the area of patent legislation that relates to pharmaceuticals, the federal government …
Persistent link: https://www.econbiz.de/10013289041
Abstract: This article discusses the prosecution of excessive pricing cases regarding pharmaceutical products under EU law in its regulatory context. In recent years the legal framework for the pursuit of such cases, based on the United Brands precedent, has been established more firmly. The...
Persistent link: https://www.econbiz.de/10013299479
This chapter describes the market for pharmaceuticals, which exceeded $500 million in sales in 2010. The industry is …
Persistent link: https://www.econbiz.de/10014025576
monthly data for pharmaceuticals prescribed from 1997 to 2005. The simulation indicates that the regulation of prices is …
Persistent link: https://www.econbiz.de/10013124304